Siemens Enters Field of Molecular Services for Oncology
Siemens Healthineers will expand its portfolio with molecular testing related services and technologies for oncology and genomics
Siemens Healthineers will expand its portfolio with molecular testing related services and technologies for oncology and genomics
Direct comparative studies now possible with a set of cancer-specific genes for DNA from tumor tissue or for circulating tumor DNA from liquid biopsy samples
Top tips to optimize your analyses
Vitrification provides excellent survivability of embryos and oocytes through the freezing process
Detects biomarkers of horse infection, inflammation, immune response and general health
Interlab comparison demonstrates Circulogene’s blood-drop-volume liquid biopsy assay is fastest, most accurate process to date for tracking and treating cancer
BioTek Instruments, Inc. presented with Scientists' Choice Award® at AACR
Research published online in the International Journal of Cancer, shows the ParsortixTM System efficiently captures and harvests intact, viable circulating tumor cells (CTCs), including EpCAM-negative CTCs, to allow for broader downstream CTC analysis
Agena Bioscience to provide Horizon’s human genomic reference standards to assess quality and performance of oncology-based assays on the MassARRAY System
MassHunter VistaFlux will help cancer researchers better understand metabolic pathways
RNA-seq Explorer Solution generates clear insights for cancer ‘omics’ analyses
Collaboration with Mirati Therapeutics targets MET gene mutations to personalize treatment
Share your expertise and vote for the product that made most difference to your research in 2015
Thermo Scientific MSIA Streptavidin EVO microcolumns simplify large molecule bioanalysis